Sign in

CIK 0001001316

  • Large accelerated filer

TG THERAPEUTICS, INC.

Sign in to watch
Ticker
TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363898269
Phone
+1 212-554-4484
Business address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
Former names
MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
  1. 4 Open-market sale CFO, Secretary and Treasurer sold 22,790 shares at $11.21 ($255,476)
  2. 4/A Grant or award WEISS MICHAEL S acquired 672,343 shares (grant or award)
  3. 4 Grant or award CFO, Secretary and Treasurer acquired 50,000 shares (grant or award)
  4. 4 Grant or award WEISS MICHAEL S acquired 6,723,443 shares (grant or award)
  5. 4 Open-market sale Director sold 17,000 shares at $17.08 ($290,360)
  6. 4 Open-market sale CFO, Secretary and Treasurer sold 50,054 shares at $16.46 ($823,889)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Director acquired 4,667 shares (grant or award)
  9. 4 Grant or award Director acquired 4,667 shares (grant or award)
  10. 4 Grant or award Director acquired 4,667 shares (grant or award)
  11. 4 Grant or award Director acquired 4,667 shares (grant or award)
  12. 4 Grant or award WEISS MICHAEL S acquired 337,257 shares (grant or award)
  13. 4 Grant or award Director acquired 4,667 shares (grant or award)
  14. 4 Open-market buy 10% owner bought 114,855 shares at $6.53 ($750,003)
  15. 4 Open-market sale CFO, Secretary and Treasurer sold 23,800 shares at an average $15.50 ($369,010)
  16. 4 Open-market sale CFO, Secretary and Treasurer sold 66,401 shares at an average $16.40 ($1,088,890)
  17. 4 Grant or award CFO, Secretary and Treasurer acquired 10,000 shares (grant or award)
  18. 4 Grant or award WEISS MICHAEL S acquired 268,603 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale WEISS MICHAEL S sold 210,618 shares at $16.44 ($3,462,560)

Page 7 of 18 · 353 filings